ArticleArchives of microbiology2025
Probing the adhesion potential of Bifidobacterium animalis subsp. lactis MCM-B-2007 via in vitro and in silico analyses.
Article in Archives of microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Exploring the Adhesion Potential ofFoods (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Bifidobacterium strains are widely recognized for their probiotic properties, and their ability to adhere to the intestinal epithelium is crucial for effective gut colonization and interaction with the host. This study offers a thorough examination of the adhesion capabilities of Bifidobacterium animalis subsp. lactis, integrating in silico analyses with in vitro adhesion assessments. Genome analysis of MCM-B-2007 identified several adhesion proteins that might act as potential mediators of crosstalk between microbes and their host. Molecular docking studies further assessed these adhesion proteins interaction with gut mucins. MCM-B-2007 displayed the highest affinity for binding to MUC4, with a predicted weighted score of -1539.5. These adhesion capabilities were subsequently validated through in vitro adhesion assays. MCM-B-2007 demonstrated a significant adhesion potential, with an adhesion efficiency of approximately 306 ± 20 bacterial cells per 100 HT-29 cells, classifying it as a strongly adhesive strain. Additionally, MCM-B-2007 demonstrated the strong competitive inhibition of adhesion of pathogenic Klebsiella pneumoniae and Salmonella Typhimurium, effectively safeguarding the host cells against infections. These findings support its use as a probiotic with the potential for future application in establishing healthy gut microbiota.
Indexed as
Identifiers
40965632What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.